Trial of anti-AIDS vaccine in Chennai lab a success
Phase I Proves Shots Safe; Next Level Tests On 300 Volunteers Jaya Menon | TNN Chennai: India's HIV vaccine programme got a major boost with scientists of the Tuberculosis Research Centre (TRC) here reporting significant progress in the first phase of clinical trials for a vaccine to prevent AIDS. Preliminary results of phase one trial have successfully proved the vaccine's safety and its ability to stimulate immune response (that might provide protection against infection), the centre's head told TOI.